Editor's Choice
PUBLIC HEALTH / CLINICAL RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Previous research suggests a potential association between physical activity (PA) and breast cancer (BC), but the causal relationship remains uncertain. The aim of this study was to explore the causal relationship between PA and BC through Mendelian randomization (MR) analysis.

Material and methods:
Genome-wide association studies utilizing data from the UK Biobank baseline were employed to analyze PA phenotypes, encompassing 460,376 participants. Summary data for BC, comprising 122,977 cases and 105,974 controls, were obtained from the BC Association Consortium. The cases were further categorized based on estrogen receptor status into estrogen receptor-positive breast cancer (ER+ BC) and estrogen receptor-negative breast cancer (ER– BC). The inverse variance weighted method was employed as the primary approach for two-sample MR. Additionally, the MR-PRESSO (MR-Pleiotropy RESidual Sum and Outlier) method was utilized to eliminate outliers. Tests for heterogeneity and pleiotropy were conducted to enhance result accuracy. Furthermore, multivariable Mendelian randomization was performed, adjusting for potential confounders to ensure result stability.

Results:
MR analysis was employed to assess the causal link between PA and BC. Two-sample MR analysis revealed a genetic prediction indicating that walking for pleasure was associated with decreased risk of ER+ BC (odds ratio (OR) = 0.302, 95% CI = 0.105–0.872, p = 0.027), while other physical activities were not significantly correlated with BC, ER+ BC and ER– BC. These findings remained reliable and consistent in the sensitivity analysis, including Cochran’s Q and MR-Egger regression. Furthermore, reverse MR analysis suggested that BC did not exert a notable impact on PA.

Conclusions:
Our findings suggest that engaging in leisure walking is associated with a reduced risk of ER+ BC. Nevertheless, additional research is warranted to comprehensively elucidate the underlying mechanisms and strengthen the causal relationship.

REFERENCES (48)
1.
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-49.
 
2.
Benitez FJ, Morgan E, de Luna AA, et al. Global stage distribution of breast cancer at diagnosis: a systematic review and meta-analysis. JAMA Oncol 2024; 10: 71-8.
 
3.
Iacoviello L, Bonaccio M, de Gaetano G, et al. Epidemiology of breast cancer, a paradigm of the “common soil” hypothesis. Semin Cancer Biol 2021; 72: 4-10.
 
4.
Ehsan AN, Wu CA, Minasian A, et al. Financial Toxicity among patients with breast cancer worldwide: a systematic review and meta-analysis. JAMA Netw Open 2023; 6: e2255388.
 
5.
Terry MB, Colditz GA. Epidemiology and risk factors for breast cancer: 21st century advances, gaps to address through interdisciplinary science. Cold Spring Harb Perspect Med 2023; 13: a041317.
 
6.
Wang H, MacInnis RJ, Li S. Family history and breast cancer risk for Asian women: a systematic review and meta-analysis. BMC Med 2023; 21: 239.
 
7.
Wang Z, Emmerich A, Pillon NJ, et al. Genome-wide association analyses of physical activity and sedentary behavior provide insights into underlying mechanisms and roles in disease prevention. Nat Genet 2022; 54: 1332-44.
 
8.
D’Amore C, Saunders S, Bhatnagar N, et al. Determinants of physical activity in community-dwelling older adults: an umbrella review. Int J Behav Nutr Phys Act 2023; 20: 135.
 
9.
Mazzucca S, Arredondo EM, Hoelscher DM, et al. Expanding implementation research to prevent chronic diseases in community settings. Annu Rev Public Health 2021; 42: 135-58.
 
10.
Mishima RS, Verdicchio CV, Noubiap JJ, et al. Self-reported physical activity and atrial fibrillation risk: a systematic review and meta-analysis. Heart Rhythm 2021; 18: 520-8.
 
11.
Lee IM, Shiroma EJ, Lobelo F, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012; 380: 219-29.
 
12.
Hassen HY, Ndejjo R, Musinguzi G, et al. Effectiveness of community-based cardiovascular disease prevention interventions to improve physical activity: a systematic review and meta-regression. Prev Med 2021; 153: 106797.
 
13.
Tomida S, Koyama T, Ozaki E, et al. Seven-plus hours of daily sedentary time and the subsequent risk of breast cancer: Japan Multi-Institutional Collaborative Cohort Study. Cancer Sci 2024; 115: 611-22.
 
14.
Wang Z, Albers FE, Wang SE, et al. Biased effects of pre-diagnostic physical activity on breast cancer survival: systematic review and meta-analysis. Cancer Epidemiol 2024; 89: 102544.
 
15.
Zhang Y, Song M, Yang Z, et al. Healthy lifestyles, systemic inflammation and breast cancer risk: a mediation analysis. BMC Cancer 2024; 24: 208.
 
16.
Sanchez-Bayona R, Gardeazabal I, Romanos-Nanclares A, et al. Leisure-time physical activity, sedentary behavior, and risk of breast cancer: results from the SUN (‘Seguimiento Universidad De Navarra’) project. Prev Med 2021; 148: 106535.
 
17.
Mussallem D. Lifestyle for breast cancer risk reduction. Menopause 2022; 29: 979-81.
 
18.
Weitzer J, Castano-Vinyals G, Aragones N, et al. Effect of time of day of recreational and household physical activity on prostate and breast cancer risk (MCC-Spain study). Int J Cancer 2021; 148: 1360-71.
 
19.
Karavasiloglou N, Pestoni G, Kuhn T, et al. Adherence to cancer prevention recommendations and risk of breast cancer in situ in the United Kingdom Biobank. Int J Cancer 2022; 151: 1674-83.
 
20.
Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA 2017; 318: 1925-6.
 
21.
Sanderson E, Glymour MM, Holmes MV, et al. Mendelian randomization. Nat Rev Methods Primers 2022; 2: 6.
 
22.
Wang C, Wu W, Yang H, et al. Mendelian randomization analyses for PCOS: evidence, opportunities, and challenges. Trends Genet 2022; 38: 468-82.
 
23.
Yuan S, Mason AM, Titova OE, et al. Morning chronotype and digestive tract cancers: Mendelian randomization study. Int J Cancer 2023; 152: 697-704.
 
24.
Hu X, Zhao J, Lin Z, et al. Mendelian randomization for causal inference accounting for pleiotropy and sample structure using genome-wide summary statistics. Proc Natl Acad Sci USA 2022; 119: e2106858119.
 
25.
Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res 2017; 26: 2333-55.
 
26.
Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 2017; 32: 377-89.
 
27.
Wu GL, Liu YZ, Zhang L. Editorial: Mendelian randomization: approach and applications. Front Genet 2021; 12: 752146.
 
28.
Richmond RC, Davey SG. Mendelian randomization: concepts and scope. Cold Spring Harb Perspect Med 2022; 12: a040501.
 
29.
Cohen JF, Chalumeau M, Cohen R, et al. Cochran’s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy. J Clin Epidemiol 2015; 68: 299-306.
 
30.
Fentie H, Ntenda P, Tiruneh FN. Dietary pattern and other factors of breast cancer among women: a case control study in Northwest Ethiopia. BMC Cancer 2023; 23: 1050.
 
31.
Akram M, Iqbal M, Daniyal M, et al. Awareness and current knowledge of breast cancer. Biol Res 2017; 50: 33.
 
32.
Donahue P, MacKenzie A, Filipovic A, et al. Advances in the prevention and treatment of breast cancer-related lymphedema. Breast Cancer Res Treat 2023; 200: 1-14.
 
33.
Herrmann SD, Willis EA, Ainsworth BE. The 2024 compendium of physical activities and its expansion. J Sport Health Sci 2024; 13: 1-2.
 
34.
Hassen F, Enquselassie F, Ali A, et al. Association of risk factors and breast cancer among women treated at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a case-control study. BMJ Open 2022; 12: e060636.
 
35.
Huerta JM, Molina AJ, Chirlaque MD, et al. Domain-specific patterns of physical activity and risk of breast cancer sub-types in the MCC-Spain study. Breast Cancer Res Treat 2019; 177: 749-60.
 
36.
Turbitt WJ, Xu Y, Sosnoski DM, et al. Physical activity plus energy restriction prevents 4T1.2 mammary tumor progression, MDSC Accumulation, and an immunosuppressive tumor microenvironment. Cancer Prev Res (Phila) 2019; 12: 493-506.
 
37.
Garritson J, Krynski L, Haverbeck L, et al. Physical activity delays accumulation of immunosuppressive myeloid-derived suppressor cells. PLoS One 2020; 15: e0234548.
 
38.
Xu Y, Rogers CJ. Impact of physical activity and energy restriction on immune regulation of cancer. Transl Cancer Res 2020; 9: 5700-31.
 
39.
Wang B, Yuan F. The association between interleukin-1beta gene polymorphisms and the risk of breast cancer: a systematic review and meta-analysis. Arch Med Sci 2022; 18: 1-10.
 
40.
Gao L, Qi X, Hu K, et al. Estrogen receptor beta promoter methylation: a potential indicator of malignant changes in breast cancer. Arch Med Sci 2016; 12: 129-36.
 
41.
Kasielska-Trojan A, Danilewicz M, Struzyna J, et al. The role of oestrogen and progesterone receptors in gigantomastia. Arch Med Sci 2022; 18: 1016-20.
 
42.
Lukanova A, Kaaks R. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 2005; 14: 98-107.
 
43.
Chung WM, Chen L, Chang WC, et al. Androgen/androgen receptor signaling in ovarian cancer: molecular regulation and therapeutic potentials. Int J Mol Sci 2021; 22: 7748.
 
44.
Gjorgoska M, Rizner TL. The effect of androgens on the risk of endometriosis sub-phenotypes and ovarian neoplasms: a Mendelian randomization study. J Steroid Biochem Mol Biol 2024; 239: 106482.
 
45.
Voudouri K, Nikitovic D, Berdiaki A, et al. IGF-I/EGF and E2 signaling crosstalk through IGF-IR conduit point affects breast cancer cell adhesion. Matrix Biol 2016; 56: 95-113.
 
46.
Caffa I, Spagnolo V, Vernieri C, et al. Fasting-mimicking diet and hormone therapy induce breast cancer regression. Nature 2020; 583: 620-4.
 
47.
Fang W, Zhou T, Shi H, et al. Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8(+) T cell exclusion. J Exp Clin Cancer Res 2021; 40: 4.
 
48.
Blomberg OS, Spagnuolo L, Garner H, et al. IL-5-producing CD4(+) T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer. Cancer Cell 2023; 41: 106-23.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top